(Total Views: 659)
Posted On: 12/25/2020 1:57:25 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: Cassandra X #69688
Your last sentence Cassandra X is more like it. I feel that the fda doesn't want to deal with all the paper work THEY have to do and that could be just one reason why open label was offered. Also, I sure hope that this can help relieve some of the pressure, as you said, in the ICU's of hospitals.
Quote: " With the open label extension for Leronlimab, what may be tested is whether Leronlimab can be used to unclog ICUs. That would be a great basis for an EUA!
The FDA also probably hopes open label will slow requests for eINDs. "
GLTU
HCIT
Quote: " With the open label extension for Leronlimab, what may be tested is whether Leronlimab can be used to unclog ICUs. That would be a great basis for an EUA!
The FDA also probably hopes open label will slow requests for eINDs. "
GLTU
HCIT
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)